Hap Trading, LLC Gossamer Bio, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $28,536 - $211,068	16,400 New	16,400 $2,000
Q2 2022 Aug 12, 2022	BUY	$5.97 - $9.97 $67,461 - $112,661	11,300 New	11,300 $9,000
Q1 2022 May 12, 2022	SELL	$8.44 - $12.49 $92,840 - $137,390	-11,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $111,319 - $154,770	11,000 New	11,000 $7,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $81.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.